Literature DB >> 3768877

Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience.

P J Walther, S D Williams, M Troner, F A Greco, R Birch, L H Einhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3768877

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 2.  Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Authors:  R S Miller; F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 3.  Role of chemotherapy in prostate cancer.

Authors:  Rita Nader; Joelle El Amm; Jeanny B Aragon-Ching
Journal:  Asian J Androl       Date:  2018 May-Jun       Impact factor: 3.285

4.  A screening of a library of T7 phage-displayed peptide identifies E2F-4 as an etoposide-binding protein.

Authors:  Mihoko Takami; Yoichi Takakusagi; Kouji Kuramochi; Senko Tsukuda; Satoko Aoki; Kengo Morohashi; Keisuke Ohta; Susumu Kobayashi; Kengo Sakaguchi; Fumio Sugawara
Journal:  Molecules       Date:  2011-05-24       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.